首页> 美国卫生研究院文献>Experimental Molecular Medicine >Lentivirus-mediated RNA interference targeting E2F-1 inhibits human gastric cancer MGC-803 cell growth in vivo
【2h】

Lentivirus-mediated RNA interference targeting E2F-1 inhibits human gastric cancer MGC-803 cell growth in vivo

机译:靶向E2F-1的慢病毒介导的RNA干扰在体内抑制人胃癌MGC-803细胞的生长

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The E2F-1 transcription factor is post-translationally modified and stabilized in response to various forms of DNA damage to regulate the expression of cell-cycle and pro-apoptotic genes. The sustained overexpression of E2F-1 is a characteristic feature of gastric cancer. In this study, we investigated the role of short hairpin RNA (shRNA) targeting E2F-1 gene on human gastric cancer MGC-803 cell growth in vivo, and preliminarily revealed the mechanism. Thus, we constructed recombinant pGCSIL-GFP-shRNA-E2F-1 lentiviral vector to knock down E2F-1 expression in human gastric cancer MGC-803 cells in vivo, and studied the effect of E2F-1 shRNA on growth of MGC-803 tumor and evaluated its treatment efficacy. Our data demonstrated that in a mouse model of established gastric cancer, intratumor injection of lentiviral shRNA targeting E2F-1 definitely decreased the endogenous E2F-1 mRNA and protein expression in MGC-803 tumor, and inhibited tumor growth and promoted tumor cells apoptosis. Moreover, we found that E2F-1 shRNA increased the expression of phosphatase and tensin homolog (PTEN), activated caspase-3 and caspase-9, and suppressed nuclear factor (NF)-κB expression in tumor tissue as determined by reverse transcription (RT)-PCR and western blotting. In summary, shRNA targeting of E2F-1 can effectively inhibits human gastric cancer MGC-803 cell growth in vivo and may be a potential therapeutic strategy for gastric cancer.
机译:E2F-1转录因子经过翻译后修饰,可响应各种形式的DNA损伤而稳定,从而调节细胞周期和促凋亡基因的表达。 E2F-1的持续过度表达是胃癌的特征。在这项研究中,我们调查了针对E2F-1基因的短发夹RNA(shRNA)在体内人胃癌MGC-803细胞生长中的作用,并初步揭示了其机制。因此,我们构建了重组pGCSIL-GFP-shRNA-E2F-1慢病毒载体,以敲低人胃癌MGC-803细胞中的E2F-1表达,并研究了E2F-1 shRNA对MGC-803肿瘤生长的影响。并评估其治疗效果。我们的数据表明,在已建立的胃癌小鼠模型中,肿瘤内注射靶向E2F-1的慢病毒shRNA无疑会降低MGC-803肿瘤中的内源性E2F-1 mRNA和蛋白表达,并抑制肿瘤生长并促进肿瘤细胞凋亡。此外,我们发现E2F-1 shRNA可通过逆转录(RT)测定增加肿瘤组织中的磷酸酶和张力蛋白同源物(PTEN),活化的caspase-3和caspase-9的表达,并抑制其核因子(NF)-κB的表达。 )-PCR和蛋白质印迹。总之,靶向E2F-1的shRNA可以在体内有效抑制人胃癌MGC-803细胞的生长,可能是胃癌的潜在治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号